tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
US Market
GPCR
Structure Therapeutics, Inc. Sponsored ADR
RESEARCH TOOLSreports

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Stock News & Sentiment

Compare
1,195 Followers
Validating IP, Extending Runway: Why Structure Therapeutics’ Oral GLP‑1 Platform Supports a Buy Rating
Premium
Ratings
Validating IP, Extending Runway: Why Structure Therapeutics’ Oral GLP‑1 Platform Supports a Buy Rating
30d ago
GPCR
Structure Therapeutics inks major GLP-1 licensing deal
Premium
Company Announcements
Structure Therapeutics inks major GLP-1 licensing deal
1M ago
8K
GPCR
Structure Therapeutics Announces $650 Million Public Offering
Premium
Company Announcements
Structure Therapeutics Announces $650 Million Public Offering
2M ago
8K
GPCR
Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
Premium
Market News
Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
2M ago
LLY
NVO
Why is Biotech Stock iBio Up over 50%?
Premium
Market News
Why is Biotech Stock iBio Up over 50%?
2M ago
EVR
LLY
Promising Outlook for Structure Therapeutics’ Aleniglipron: Buy Rating Affirmed Amid Strong Phase 2b Results and Market Potential
Premium
Ratings
Promising Outlook for Structure Therapeutics’ Aleniglipron: Buy Rating Affirmed Amid Strong Phase 2b Results and Market Potential
2M ago
GPCR
Promising Potential of Structure Therapeutics’ Aleniglipron: A Buy Rating Based on Transformative Efficacy and Strategic Innovation
Premium
Ratings
Promising Potential of Structure Therapeutics’ Aleniglipron: A Buy Rating Based on Transformative Efficacy and Strategic Innovation
2M ago
GPCR
More GPCR News >

GPCR News on the Web

Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
TipRanks News
Bullish
Structure Therapeutics emerges as top M&A target for big pharma, Axios says
TipRanks News
Bullish
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC
Bullish
Structure Therapeutics price target raised to $105 from $65 at JPMorgan
TipRanks News
Bullish
Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
CNBC
Bullish
LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling
Zacks
Bullish
Why Structure Therapeutics Inc.’s (GPCR) Stock Is Up 5.25%
AAII
Neutral
How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results?
Zacks
Bullish

News Score - Last 7 Days

Positive
GPCR
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GPCR’s Media Buzz Sentiment?
2 articles about GPCR were published this week. In an average week, 4.25 articles are published.
    What is GPCR’s weekly average amount of articles?
    In an average week, 4.25 articles about GPCR are published.
      What is GPCR’s News Sentiment?
      100% of articles about GPCR were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        0OLDadidas AG
        0NX2ABB Ltd
        III3i Group plc
        SVASinovac Biotech
        0R6RAxfood AB
        Showing the stocks with the most bullish news sentiment over the past week